English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/93478
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

PARP-1 Regulates Metastatic Melanoma through Modulation of Vimentin-induced Malignant Transformation

AuthorsRodríguez, María Isabel; Peralta, Andreína; O'Valle, Francisco; Rodríguez-Vargas, José Manuel; González-Flores, Ariannys; Majuelos-Melguizo, Jara; López, Laura; Serrano, S.; García de Herreros, Antonio; Rodríguez-Manzaneque, Juan Carlos; Fernández, R.; Moral, Raimundo del; Almodóvar, José Mariano de; Oliver, Francisco Javier
Issue Date2013
PublisherPublic Library of Science
CitationPLoS Genetics 9 (2013)
AbstractPARP inhibition can induce anti-neoplastic effects when used as monotherapy or in combination with chemo- or radiotherapy in various tumor settings; however, the basis for the anti-metastasic activities resulting from PARP inhibition remains unknown. PARP inhibitors may also act as modulators of tumor angiogenesis. Proteomic analysis of endothelial cells revealed that vimentin, an intermediary filament involved in angiogenesis and a specific hallmark of EndoMT (endothelial to mesenchymal transition) transformation, was down-regulated following loss of PARP-1 function in endothelial cells. VE-cadherin, an endothelial marker of vascular normalization, was up-regulated in HUVEC treated with PARP inhibitors or following PARP-1 silencing; vimentin over-expression was sufficient to drive to an EndoMT phenotype. In melanoma cells, PARP inhibition reduced pro-metastatic markers, including vasculogenic mimicry. We also demonstrated that vimentin expression was sufficient to induce increased mesenchymal/pro-metastasic phenotypic changes in melanoma cells, including ILK/GSK3-β-dependent E-cadherin down-regulation, Snail1 activation and increased cell motility and migration. In a murine model of metastatic melanoma, PARP inhibition counteracted the ability of melanoma cells to metastasize to the lung. These results suggest that inhibition of PARP interferes with key metastasis-promoting processes, leading to suppression of invasion and colonization of distal organs by aggressive metastatic cells. © 2013 Rodríguez et al.
URIhttp://hdl.handle.net/10261/93478
DOI10.1371/journal.pgen.1003531
Identifiersdoi: 10.1371/journal.pgen.1003531
issn: 1553-7390
e-issn: 1553-7404
Appears in Collections:(IPBLN) Artículos
Files in This Item:
File Description SizeFormat 
journal.pgen.1003531.pdf1,69 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.